Univercells S.A.

https://www.univercells.com

LinkedIn: https://www.linkedin.com/company/univercells

Univercells is a business-to-business provider focused on increasing the availability of affordable vaccines and biotherapeutics to address global health challenges. The company is developing turnkey solutions for a series of vaccines and biotherapeutics to be delivered at an affordable price. By relying on proprietary core technologies and a continuous process intensification approach, production is achieved with a smaller footprint, and significantly lower overall capital and operational costs. Global company headquartered in Gosselies (Belgium), Univercells benefits from the support regional and national players as well as from the Bill & Melinda Gates Foundation, Global Health Investment Fund and other international players in the health and vaccine industry. *

	Start	2013-01-01 established
	Group	Univercells (Group)
	Industry	contract manufacturing (biologicals)
	Industry 2	vaccine
	Person	Bultot, Hugues (Univercells 2013– CEO + Co-Founder)
	Person 2	Castillo, José (Qunatoom Biosciences 202106– CEO + Univercells 2013– CTO + Co-Founder before Artelis 201011 President)

	Region	Gosselies
	Country	Belgium
	Street	48 Rue Auguste Piccard
	City	6041 Gosselies
	Tel	+32-2-318-8348
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Univercells S.A.. (10/3/19). "Press Release: Univercells Boosted by EUR 20m European Financing to Accelerate the Delivery of Its Vaccine Portfolio". Brussels.

		Record changed: 2024-02-12